Cargando…

Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer

BACKGROUND: Sagopilone is the first fully synthetic epothilone in clinical development and has demonstrated promising preclinical activity. This phase I/II, prospective, open-label trial investigated the efficacy and safety of sagopilone plus carboplatin in patients with recurrent platinum-sensitive...

Descripción completa

Detalles Bibliográficos
Autores principales:	McMeekin, S, Patel, R, Verschraegen, C, Celano, P, Burke, J, Plaxe, S, Ghatage, P, Giurescu, M, Stredder, C, Wang, Y, Schmelter, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251849/ https://www.ncbi.nlm.nih.gov/pubmed/22108514 http://dx.doi.org/10.1038/bjc.2011.499

Ejemplares similares

Weekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with refractory solid tumours: results of a phase I trial
por: Arnold, D, et al.
Publicado: (2009)

Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group
por: Stupp, R., et al.
Publicado: (2011)

Molecular Mode of Action and Role of TP53 in the Sensitivity to the Novel Epothilone Sagopilone (ZK-EPO) in A549 Non-Small Cell Lung Cancer Cells
por: Winsel, Sebastian, et al.
Publicado: (2011)

Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: a phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium
por: Beer, T M, et al.
Publicado: (2012)

Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma
por: DeConti, R C, et al.
Publicado: (2010)

Enabling Blockchain Services for IoE with Zk-Rollups
por: Lavaur, Thomas, et al.
Publicado: (2022)

A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study
por: Bafaloukos, Dimitrios, et al.
Publicado: (2010)

A phase I and pharmacokinetic study of intraperitoneal carboplatin and etoposide.
por: McClay, E. F., et al.
Publicado: (1993)

Evaluation of Activity and Combination Strategies with the Microtubule-Targeting Drug Sagopilone in Breast Cancer Cell Lines
por: Eschenbrenner, Julia, et al.
Publicado: (2011)

A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens
por: Krasner, C N, et al.
Publicado: (2007)

Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss
por: Rauner, Martina, et al.
Publicado: (2021)

Combination chemotherapy with taxane and platinum in patients with salivary gland carcinoma: a retrospective study of docetaxel plus cisplatin and paclitaxel plus carboplatin
por: Onaga, Ryutaro, et al.
Publicado: (2023)

Prescribing in Northern Ireland. Study No. 2: systematic anti-infectives.
por: Elmes, P. C., et al.
Publicado: (1978)

Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients
por: Wagner, U, et al.
Publicado: (2012)

Potential inhibitory effects of compounds ZK-PI-5 and ZK-PI-9 on trehalose and chitin metabolism in Spodoptera frugiperda (J. E. Smith)
por: Zhong, Fan, et al.
Publicado: (2023)

Efficacy of birinapant in combination with carboplatin in targeting platinum-resistant epithelial ovarian cancers
por: Singh, Tanya, et al.
Publicado: (2022)

Genetic variants of erythropoietin (EPO) and EPO receptor genes in familial erythrocytosis
por: Vočanec, Danijela, et al.
Publicado: (2018)

EPOS Abstract Book
Publicado: (2022)

Welcome to EPOS 2023
por: Sanpera, Ignacio, et al.
Publicado: (2023)

EPOS Abstract Book
Publicado: (2023)

Reduced EPO receptor expression may contribute to limited pleiotropic effects of EPO during critical illness
por: McCook, O, et al.
Publicado: (2012)

Synthesis of Binderless ZK-4 Zeolite Microspheres at High Temperature
por: Fawaz, Elyssa G., et al.
Publicado: (2018)

Comparison of the short-term efficacy between docetaxel plus carboplatin and 5-fluorouracil plus carboplatin in locoregionally advanced nasopharyngeal carcinoma
por: Lv, Xing, et al.
Publicado: (2016)

Successful Treatment with Pemetrexed, Carboplatin, and Bevacizumab for Platinum-Resistant Adenocarcinoma of the Lung
por: Wada, Sae, et al.
Publicado: (2012)

Are we as depressed as we think we are?
por: King, D. J., et al.
Publicado: (1977)

Annual report for 1976 of the Belfast Poisons Information Service.
por: McMeekin, C., et al.
Publicado: (1978)

Annual Report for 1977 of the Belfast Poisons Information Service.
por: McMeekin, C., et al.
Publicado: (1979)

The 1α,25(OH)(2)D(3) Analogs ZK159222 and ZK191784 Show Anti-Inflammatory Properties in Macrophage-Induced Preadipocytes via Modulating the NF-κB and MAPK Signaling
por: Zhu, Jingjing, et al.
Publicado: (2020)

Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study
por: Benson, Eric A., et al.
Publicado: (2015)

How to pursue EPO in MS
por: Bartels, Claudia, et al.
Publicado: (2017)

Retrospective Analysis Of Comparative Outcomes In Recurrent Platinum-Sensitive Ovarian Cancer Treated With Pegylated Liposomal Doxorubicin (Lipo-Dox) And Carboplatin Versus Paclitaxel And Carboplatin
por: Weng, Chia-Sui, et al.
Publicado: (2019)

Irinotecan plus carboplatin for patients with carcinoma of unknown primary site
por: Yonemori, K, et al.
Publicado: (2009)

An evaluation of the Eppendorf EPOS 5060 biochemistry autoanalyser
por: Antoja, F., et al.
Publicado: (1987)

Comparison of Neoadjuvant Chemotherapy Efficiency in Advanced Ovarian Cancer Patients Treated With Paclitaxel Plus Carboplatin and Intraperitoneal Bevacizumab vs. Paclitaxel With Carboplatin
por: Tao, Yin, et al.
Publicado: (2022)

Development of an Efficient Electroporation Method for Iturin A-Producing Bacillus subtilis ZK
por: Zhang, Zhi, et al.
Publicado: (2015)

Effect of heat treatment on mechanical and biodegradable properties of an extruded ZK60 alloy
por: Chen, Junxiu, et al.
Publicado: (2016)

Biodegradation behavior of magnesium and ZK60 alloy in artificial urine and rat models
por: Zhang, Shiying, et al.
Publicado: (2017)

Microstructure and Corrosion of Cast Magnesium Alloy ZK60 in NaCl Solution
por: Li, Zhen, et al.
Publicado: (2020)

EPO‐receptor is present in mouse C2C12 and human primary skeletal muscle cells but EPO does not influence myogenesis
por: Lamon, Séverine, et al.
Publicado: (2014)

Prescribing in Northern Ireland. Study no. 1: Sleeping tablets.
por: Elmes, P. C., et al.
Publicado: (1976)

Cannot write session to /tmp/vufind_sessions/sess_f7a2e06qad4ae2ft3pjvl15mvn